Golebiowski Filip, Szulc Aneta, Szutowicz Andrzej, Pawelczyk Tadeusz
Department of Molecular Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland.
Arch Biochem Biophys. 2004 Aug 15;428(2):160-4. doi: 10.1016/j.abb.2004.05.020.
Fhit protein is the product of the putative tumor suppressor fragile histidine triad (FHIT) gene. The way by which Fhit exerts its antitumor activity remains largely unknown, although the Fhit-Ap3A complex is believed to be the native signaling form of Fhit. Here, we have shown that Fhit protein interacts with hUbc9, a recombinant human SUMO-1 conjugating enzyme, in an adenosine(5')triphospho(5')nucleoside (Ap3N)-dependent manner. Our experiments showed that the dinucleoside polyphosphate hydrolase activity of Fhit is suppressed by interacting with hUbc9 protein. In the presence of equimolar hUbc9 the Vmax and Km activity of Fhit was decreased by 35%. Analysis of Fhit kinetics in the presence of different fixed concentrations of Ubc9 showed that Ubc9 is an uncompetitive inhibitor. Including SUMO-1 protein in the assay neither affected the Fhit activity nor modified the effect of Ubc9 on Fhit kinetics. Our data suggest that hUbc9-induced inhibition of Fhit may result in an elongation of the Fhit-Ap3A signaling complex lifetime leading to alteration of its antitumor activity.
脆性组氨酸三联体(FHIT)蛋白是假定的肿瘤抑制基因FHIT的产物。尽管Fhit-Ap3A复合物被认为是Fhit的天然信号传导形式,但Fhit发挥其抗肿瘤活性的方式在很大程度上仍不清楚。在此,我们已经表明,Fhit蛋白以腺苷(5')三磷酸(5')核苷(Ap3N)依赖性方式与重组人SUMO-1缀合酶hUbc9相互作用。我们的实验表明,Fhit的二核苷多磷酸水解酶活性通过与hUbc9蛋白相互作用而受到抑制。在等摩尔hUbc9存在下,Fhit的Vmax和Km活性降低了35%。在不同固定浓度的Ubc9存在下对Fhit动力学的分析表明,Ubc9是一种非竞争性抑制剂。在测定中加入SUMO-1蛋白既不影响Fhit活性,也不改变Ubc9对Fhit动力学的影响。我们的数据表明,hUbc9诱导的Fhit抑制可能导致Fhit-Ap3A信号复合物寿命延长,从而改变其抗肿瘤活性。